Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Holmium-Containing Bioactive Glasses Dispersed in Poloxamer 407 Hydrogel as a Theragenerative Composite for Bone Cancer Treatment

Texto completo
Autor(es):
Zambanini, Telma [1] ; Borges, Roger [1] ; de Souza, Ana C. S. [1] ; Justo, Giselle Z. [2] ; Machado, Jr., Joel [3] ; de Araujo, Daniele R. [1] ; Marchi, Juliana [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09210580 Santo Andre, SP - Brazil
[2] Univ Fed Sao Paulo, Dept Bioquim, BR-04044020 Sao Paulo, SP - Brazil
[3] Univ Fed Sao Paulo, Dept Ciencias Biol, BR-04039032 Diadema, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: MATERIALS; v. 14, n. 6 MAR 2021.
Citações Web of Science: 0
Resumo

Holmium-containing bioactive glasses can be applied in bone cancer treatment because the holmium content can be neutron activated, having suitable properties for brachytherapy applications, while the bioactive glass matrix can regenerate the bone alterations induced by the tumor. To facilitate the application of these glasses in clinical practice, we proposed a composite based on Poloxamer 407 thermoresponsive hydrogel, with suitable properties for applications as injectable systems. Therefore, in this work, we evaluated the influence of holmium-containing glass particles on the properties of Poloxamer 407 hydrogel (20 w/w.%), including self-assembly ability and biological properties. 58S bioactive glasses (58SiO(2)-33CaO-9P(2)O(5)) containing different Ho2O3 amounts (1.25, 2.5, 3.75, and 5 wt.%) were incorporated into the hydrogel. The formulations were characterized by scanning electron microscopy, differential scanning calorimetry, rheological tests, and {[}3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] MTT cell viability against pre-osteoblastic and osteosarcoma cells. The results evidenced that neither the glass particles dispersed in the hydrogel nor the holmium content in the glasses significantly influenced the hydrogel self-assembly ability (T-mic similar to 13.8 degrees C and T-gel similar to 20 degrees C). Although, the glass particles considerably diminished the hydrogel viscosity in one order of magnitude at body temperature (37 degrees C). The cytotoxicity results evidenced that the formulations selectively favored pre-osteoblastic cell proliferation and osteosarcoma cell death. In conclusion, the formulation containing glass with the highest fraction of holmium content (5 wt.%) had the best biological results outcomes aiming its application as theragenerative materials for bone cancer treatment. (AU)

Processo FAPESP: 16/16512-9 - Desenvolvimento de um sistema carreador para liberação simultânea de fármaco e íons provenientes de vidros biocompatíveis a partir de uma matriz de hidrogel com os objetivos de auxiliar no tratamento de câncer ósseo e estimular a reparação óssea
Beneficiário:Juliana Marchi
Modalidade de apoio: Auxílio à Pesquisa - Regular